Neonatal L-monosodium glutamate (MSG) administration in rats induces several neuroendocrine and metabolic disruptions. Leptin, the adipocyte product, modulates several neuroendocrine systems including the hypothalamic-pituitary-gonadal (HPG) axis in mammals. The aim of the present study was to determine whether MSG-induced chronic hyperleptinemia could play any relevant role in the hypogonadism developed by male rats when examined in adulthood. We found that 120-day-old MSG male rats displayed significant hyperleptinemia, hypogonadism, and undisturbed basic testis structure and spermatogenesis. In vitro studies in purified Leydig cells from normal (CTR) and MSG-damaged rats revealed that basal and human chorionic gonadotropin (hCG)-stimulated 17-hydroxy-progesterone (17-HO-P4), Δ4-androstenedione (Δ4A) and testosterone (T) secretions were significantly lower in MSG than in CTR cells. Exposure to murine leptin (m leptin, 10–8M) significantly inhibited hCG-elicited T secretion by CTR cells after 180 min incubation. While m leptin significantly inhibited hCG-stimulated Δ4A output and the Δ4A:17-OH-P4 ratio of secretion, conversely, it failed to modify the ratio T:Δ4A release by CTR Leydig cells. Interestingly, the effects of m leptin found on CTR Leydig cells were absent in MSG Leydig cells. Finally, endogenous hyperleptinemia was associated with a significant decrease in Leydig cell expression of Ob-Rb mRNA in MSG rats. In summary, this study demonstrates that: (1) m leptin inhibited testicular steroidogenesis in CTR rats; (2) MSG-treated rats showed lower in vitro 17-OH-P4, Δ4A and T production under basal and post-hCG stimulation conditions; (3) purified Leydig cells from MSG-treated rats displayed resistance to the inhibitory action of m leptin on T release, and (4) endogenous leptin exerts a modulatory effect on Leydig cell Ob-Rb mRNA expression. The inhibitory effect of leptin on testicular function is thus abrogated in MSG-damaged rats. The testicular leptin-resistance developed by MSG rats seems to be due to early chronic exposure of Leydig cells to high leptin circulating levels, which in turn down-regulate testicular Ob-Rb expression. It remains to be determined whether the testicular dysfunction of MSG rats can be reversed after correction of hyperleptinemia or whether it is an irreversible effect of the hypothalamic lesion.

Keywords:
Leptin, Testis, Steroidogenesis, Hypogonadism, Gonadal steroids, Leydig cells, Monosodium glutamate
1.
Wauters M, Considine RV, Van Gaal LF: A review: Human leptin: from an adipocyte hormone to an endocrine mediation. Eur J Endocrinol 2000;143:293–311.
2.
Barash IA, Cheung CC, Weigle DS, Ren H, Kabigting EB, Kuijper JL, Clifton DK, Steiner RA: Leptin is a metabolic signal to the reproductive system. Endocrinology 1996;137:3144–3147.
3.
Garcia-Mayor RV, Andrade MA, Rios M, Lage M, Dieguez C, Casanueva FF: Serum leptin levels in normal children: Relationship to age, gender body mass index, pituitary-gonadal hormones and pubertal stage. J Clin Endocrinol Metab 1997;82:2849–2855.
4.
Smith GD, Jackson LM, Foster DL: Leptin regulation of reproductive function and fertility. Theriogenology 2002;57:73–86.
5.
Woller M, Tessmer S, Neff D, Nguema AA, Van Roo B, Waechter-Brulla D: Leptin stimulates gonadotropin releasing hormone release from cultured intact hemihypothalami and enzymatically dispersed neurons. Exp Biol 2001;226:591–596.
6.
Ogura K, Irahara M, Kiyokawa M, Tezuka M, Matsuzaki T, Yasui T, Kamada M, Aono T: Effects of leptin on secretion of LH and FSH from primary cultured female rat pituitary cells. Eur J Endocr 2001;144:653–658.
7.
Tena-Sempere M, Manna PR, Zhang FP, Pinilla L, González C, Dieguez CL, Huhtaniemi I, Aguilar EJ: Molecular mechanism of leptin action in adult rat testis: Potential targets for leptin-induced inhibition of steroidogenesis and pattern of leptin receptor messenger ribonucleic acid expression. J Endocrinol 2001;170:413–423.
8.
Considine RV, Considine EI, Williams CJ, Hyde TM, Caro JF: The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db and fa/fa rat mutations. Diabetes 1996;19:992–994.
9.
Caprio M, Isidori AM, Carta AR, Moretti C, Dufau ML, Fabbri A: Expression of functional leptin receptors in rodent Leydig cells. Endocrinology 1999;140:4939–4947.
10.
Tena-Sempere M, Pinilla L, González LC, Dieguez C, Casanueva FF, Aguilar E: Leptin inhibits testosterone secretion from adult rat testis in vitro. J Endocrinol 1999;161:211–218.
11.
El-Hefnany T, Ioffe S, Dym M: Expression of the leptin receptor during germ cell development in the mouse testis. Endocrinology 2000;141:2624–2630.
12.
Caprio M, Fabbrini E, Isidori AM, Aversa A, Fabbri A: Review: Leptin in reproduction. Trends Endocrinol Metab 2001;12:65–72.
13.
Redding TW, Schally AV, Arimura A, Wakabayashi I: Effect of monosodium glutamate on some endocrine functions. Neuroendocrinology 1971;8:245–255.
14.
Spinedi E, Johnston C, Negro-Vilar A: Increased responsiveness of the hypothalamic pituitary axis after neurotoxin-induced hypothalamic denervation. Endocrinology 1984;115:267–272.
15.
Giovambattista A, Chisari A, Gaillard RC, Spinedi E: Food intake-induced leptin secretion, modulates hypothalamo-pituitary-adrenal axis response and hypothalamic Ob-Rb expression to insulin administration. Neuroendocrinology 2000;72:341–349.
16.
Suescun MO, Calandra RS, Lustig L: Alterations of Testicular function after induced autoimmune orchitis in rats. J Androl 1994;15:442–448.
17.
Suescun MO, Calandra RS, Lustig L: Increased testosterone production in vitro by Leydig cells from rats with severe autoimmune orchitis. Intern J Androl 1997;20:339–346.
18.
Suescun MO, Gonzalez SI, Chiauzzi VA, Calandra RS: Effects of induced hypoprolactinemia on testicular function during gonadal maturation in the rat. J Androl 1985;6:77–82.
19.
Suescun MO, Campo S, Rivarola MA, Gonzalez-Echeverría F, Scorticati C, Ghirlanda J, Tezón J, Blaquier JA, Calandra RS: Testosterone, dihydrotestosterone and zinc concentrations in human testis and epididymis. Arch Androl 1981;7:297–303.
20.
Russell LD, Ettlin LA, Sinha Hikim AP, Clegg ED: Histological and Histopathological Evaluation of the Testis. Vienna, Cache River Press, 1990, p 286.
21.
Lefévre A, Saez JM, Finaz C: hCG responsiveness of purified Leydig cells from immature and mature rats. Horm Res 1983;17:114–120.
22.
Levy H, Deane HW, Rubin BL: Visualization of steroid 3β-ol dehydrogenase activity in tissues of intact and hypophysectomized rats. Endocrinology 1959;65:932–943.
23.
Chomczynski P, Sacchi N: Single-step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Ann Biochem 1987;162:156–159.
24.
Zar JH: Biostatistical Analysis. Englewood Cliffs, Prentice-Hall, 1974.
25.
Giovambattista A, Suescun MO, Calandra RS, Spinedi E: Effects of leptin on testicular steroidogenesis in normal and hyperleptinemic rats. Endocr Soc USA, 2002, abstr, pp 3–60.
26.
Giovambattista A, Suescun MO, Aberer J, Calandra RS, Spinedi E: Differences in the pattern of circulating leptin between normal and hyperleptinemic rats over development. Endocr Soc USA, 2003, abstr, p 24.
27.
Nemeroff CB, Konkol RJ, Bissette G, Younngblood W, Martin JB, Brazeau P, Rone MS, Prangge AJ Jr, Breese GR, Kizer JS: Analysis of the disruption in hypothalamic-pituitary regulation in rats treated neonatally with monosodium L-glutamate (MSG): Evidence for the involvement of tuberoinfundibular cholinergic and dopaminergic system in neuroendocrine regulation. Endocrinology 1977;101:613–622.
28.
Mendis-Handagama SML, Ariyaratne HB: Differentiation of adult Leydig cell population in the postnatal testis. Biol Reprod 2001;65:660–671.
29.
Nessralla CDL, Giovambattista A, Suescun MO, Calandra RS, Spinedi E, Franca LR: Effects of leptin on the pituitary-testicular axis during testis development in rats. Am Soc Andrology, USA, 2003, abstr 101.
30.
Chen GF, Ronis MJJ, Thomas PE, Flint DJ, Badger TM: Hormonal regulation of microsomal cytochrome P450 2C11 in rat liver and kidney. J Pharmacol Exp Ther 1997;283:1486–1494.
31.
Shapiro BH, Pampori NA, Ram PA, Waxman DJ: Irreversible suppression of growth hormone-dependent cytochrome P450 2C11 in adult rats neonatally treated with monosodium glutamate. J Pharmacol Exp Ther 1993;265:979–984.
32.
Pampori NA, Shapiro BH: Over-expression of CYP2C11, the major male-specific form of hepatic cytocrome P450, in the presence of nominal pulses of circulating growth hormone in adult male rats neonatally exposed to low levels of monosodium glutamate. J Pharmacol Exp Ther 1994;271:1067–1073.
33.
33.Tsai-Morris CH, Khanum A, Tang PZ, Dufau ML: The rat 17β-hydroxysteroid dehydrogenase type III: Molecular cloning and gonadotropin regulation. Endocrinology 1999;140:3534–3542.
34.
Wabitsch M, Ballauff A, Holl R, Blum WF, Heinze E, Remschhmidt H, Hedebrand J: Serum leptin, gonadotropin, and testosterone concentrations in male patients with anorexia nervosa during weight gain. J Clin Endocrinol Metab 2001;86:2982–2988.
35.
Strobel A, Issad T, Camión L, Ozata M, Strosberg AD: A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998;18:213–215.
36.
Ahima RS, Dushay J, Flier SN, Prabakaran D, Flier JS: Leptin accelerates the onset of puberty in normal female mice. J Clin Invest 1997;99:391–395.
37.
Suter KJ, Pohl CR, Wilson ME: Circulating concentrations of nocturnal leptin, growth hormone, and insulin-like growth factor-I increase before the onset of puberty in agonadal male monkeys: Potential signals for the initiation puberty. J Clin Endorinol Metab 2000;85:808–814.
38.
Tena-Sempere M, Pinilla L, González LC, Casanueva FF, Dieguez C, Aguilar E: Homologous and heterologous down-regulation of leptin receptor messenger ribonucleic acid in rat adrenal gland. J Endocrinol 2000;167:479–486.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.